S. Aureus Cas9 Leads to Higher Sickle Mutation Correction Compared to S. Pyogenes Cas9 in Patient Hematopoietic Stem and Progenitor Cells

MLA

Vivien A. Sheehan, et al. “S. Aureus Cas9 Leads to Higher Sickle Mutation Correction Compared to S. Pyogenes Cas9 in Patient Hematopoietic Stem and Progenitor Cells.” Blood, vol. 138, Nov. 2021, p. 1861. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e1cd316b5df0a0174035c557a7616909&authtype=sso&custid=ns315887.

APA

Vivien A. Sheehan, Byoungyong Yoo, Gang Bao, So Hyun Julie Park Park, & Yankai Zhang. (2021). S. Aureus Cas9 Leads to Higher Sickle Mutation Correction Compared to S. Pyogenes Cas9 in Patient Hematopoietic Stem and Progenitor Cells. Blood, 138, 1861.

Chicago

Vivien A. Sheehan, Byoungyong Yoo, Gang Bao, So Hyun Julie Park Park, and Yankai Zhang. 2021. “S. Aureus Cas9 Leads to Higher Sickle Mutation Correction Compared to S. Pyogenes Cas9 in Patient Hematopoietic Stem and Progenitor Cells.” Blood 138 (November): 1861. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e1cd316b5df0a0174035c557a7616909&authtype=sso&custid=ns315887.